{"id":34760,"date":"2025-06-05T16:27:00","date_gmt":"2025-06-05T08:27:00","guid":{"rendered":"https:\/\/flcube.com\/?p=34760"},"modified":"2025-06-05T16:27:00","modified_gmt":"2025-06-05T08:27:00","slug":"easton-pharmas-oxazepam-receives-nmpa-approval-and-partners-with-nhwa","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=34760","title":{"rendered":"Easton Pharma’s Oxazepam Receives NMPA Approval and Partners with Nhwa"},"content":{"rendered":"\n

Chengdu-based Easton Pharmaceutical Co., Ltd. (SHA: 688513<\/a>) announced that its oxazepam has received marketing approval from China’s National Medical Products Administration (NMPA). This milestone paves the way for the commercialization of oxazepam in China. In a strategic move, Jiangsu Nhwa Pharmaceutical Co., Ltd. (SHE: 002262<\/a>), a compatriot firm, has entered into an exclusive commercialization agreement with Easton Pharma. This partnership aims to leverage Nhwa Pharma’s established commercial platform and distribution network to accelerate the market penetration and clinical adoption of oxazepam.<\/p>\n\n\n\n

Oxazepam’s Therapeutic Profile<\/strong>
Oxazepam, a short-acting benzodiazepine, is indicated for short-term relief of anxiety, tension, agitation, hypnotic use, adjunctive therapy for anxiety-associated depressive symptoms, and management of acute alcohol withdrawal symptoms. It stands out from traditional anxiolytics with its rapid onset of action, favorable safety profile, and lower risk of dependence, making it ideal for short-term treatment.<\/p>\n\n\n\n

Market Context<\/strong>
According to NMPA records, only three domestic manufacturers currently hold approval for oxazepam tablets in China: Beijing Yimin Pharmaceutical Co. Ltd., Hunan Dongting Pharmaceutical Co. Ltd., and now Easton Pharma. Among these, Hunan Dongting and Easton Pharma have passed the generic quality consistency evaluation for their respective versions of the drug.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Chengdu-based Easton Pharmaceutical Co., Ltd. (SHA: 688513) announced that its oxazepam has received marketing approval…<\/p>\n","protected":false},"author":1,"featured_media":34761,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[557,1472,1008,1471],"class_list":["post-34760","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-easton-pharmaceutical","tag-nhwa-pharmaceutical","tag-sha-688513","tag-she-002262"],"yoast_head":"\nEaston Pharma's Oxazepam Receives NMPA Approval and Partners with Nhwa - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Chengdu-based Easton Pharmaceutical Co., Ltd. (SHA: 688513) announced that its oxazepam has received marketing approval from China's National Medical Products Administration (NMPA). This milestone paves the way for the commercialization of oxazepam in China. In a strategic move, Jiangsu Nhwa Pharmaceutical Co., Ltd. (SHE: 002262), a compatriot firm, has entered into an exclusive commercialization agreement with Easton Pharma. This partnership aims to leverage Nhwa Pharma's established commercial platform and distribution network to accelerate the market penetration and clinical adoption of oxazepam.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=34760\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Easton Pharma's Oxazepam Receives NMPA Approval and Partners with Nhwa\" \/>\n<meta property=\"og:description\" content=\"Chengdu-based Easton Pharmaceutical Co., Ltd. (SHA: 688513) announced that its oxazepam has received marketing approval from China's National Medical Products Administration (NMPA). This milestone paves the way for the commercialization of oxazepam in China. In a strategic move, Jiangsu Nhwa Pharmaceutical Co., Ltd. (SHE: 002262), a compatriot firm, has entered into an exclusive commercialization agreement with Easton Pharma. This partnership aims to leverage Nhwa Pharma's established commercial platform and distribution network to accelerate the market penetration and clinical adoption of oxazepam.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=34760\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-05T08:27:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/0501.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Easton Pharma’s Oxazepam Receives NMPA Approval and Partners with Nhwa\",\"datePublished\":\"2025-06-05T08:27:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760\"},\"wordCount\":207,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/0501.webp\",\"keywords\":[\"Easton Pharmaceutical\",\"Nhwa Pharmaceutical\",\"SHA: 688513\",\"SHE: 002262\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34760#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=34760\",\"name\":\"Easton Pharma's Oxazepam Receives NMPA Approval and Partners with Nhwa - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/0501.webp\",\"datePublished\":\"2025-06-05T08:27:00+00:00\",\"description\":\"Chengdu-based Easton Pharmaceutical Co., Ltd. (SHA: 688513) announced that its oxazepam has received marketing approval from China's National Medical Products Administration (NMPA). This milestone paves the way for the commercialization of oxazepam in China. In a strategic move, Jiangsu Nhwa Pharmaceutical Co., Ltd. (SHE: 002262), a compatriot firm, has entered into an exclusive commercialization agreement with Easton Pharma. This partnership aims to leverage Nhwa Pharma's established commercial platform and distribution network to accelerate the market penetration and clinical adoption of oxazepam.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34760\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/0501.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/0501.webp\",\"width\":1080,\"height\":608,\"caption\":\"Easton Pharma's Oxazepam Receives NMPA Approval and Partners with Nhwa\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34760#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Easton Pharma’s Oxazepam Receives NMPA Approval and Partners with Nhwa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Easton Pharma's Oxazepam Receives NMPA Approval and Partners with Nhwa - Insight, China's Pharmaceutical Industry","description":"Chengdu-based Easton Pharmaceutical Co., Ltd. (SHA: 688513) announced that its oxazepam has received marketing approval from China's National Medical Products Administration (NMPA). This milestone paves the way for the commercialization of oxazepam in China. In a strategic move, Jiangsu Nhwa Pharmaceutical Co., Ltd. (SHE: 002262), a compatriot firm, has entered into an exclusive commercialization agreement with Easton Pharma. This partnership aims to leverage Nhwa Pharma's established commercial platform and distribution network to accelerate the market penetration and clinical adoption of oxazepam.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=34760","og_locale":"en_US","og_type":"article","og_title":"Easton Pharma's Oxazepam Receives NMPA Approval and Partners with Nhwa","og_description":"Chengdu-based Easton Pharmaceutical Co., Ltd. (SHA: 688513) announced that its oxazepam has received marketing approval from China's National Medical Products Administration (NMPA). This milestone paves the way for the commercialization of oxazepam in China. In a strategic move, Jiangsu Nhwa Pharmaceutical Co., Ltd. (SHE: 002262), a compatriot firm, has entered into an exclusive commercialization agreement with Easton Pharma. This partnership aims to leverage Nhwa Pharma's established commercial platform and distribution network to accelerate the market penetration and clinical adoption of oxazepam.","og_url":"https:\/\/flcube.com\/?p=34760","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-06-05T08:27:00+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/0501.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=34760#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=34760"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Easton Pharma’s Oxazepam Receives NMPA Approval and Partners with Nhwa","datePublished":"2025-06-05T08:27:00+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=34760"},"wordCount":207,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=34760#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/0501.webp","keywords":["Easton Pharmaceutical","Nhwa Pharmaceutical","SHA: 688513","SHE: 002262"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=34760#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=34760","url":"https:\/\/flcube.com\/?p=34760","name":"Easton Pharma's Oxazepam Receives NMPA Approval and Partners with Nhwa - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=34760#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=34760#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/0501.webp","datePublished":"2025-06-05T08:27:00+00:00","description":"Chengdu-based Easton Pharmaceutical Co., Ltd. (SHA: 688513) announced that its oxazepam has received marketing approval from China's National Medical Products Administration (NMPA). This milestone paves the way for the commercialization of oxazepam in China. In a strategic move, Jiangsu Nhwa Pharmaceutical Co., Ltd. (SHE: 002262), a compatriot firm, has entered into an exclusive commercialization agreement with Easton Pharma. This partnership aims to leverage Nhwa Pharma's established commercial platform and distribution network to accelerate the market penetration and clinical adoption of oxazepam.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=34760#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=34760"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=34760#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/0501.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/0501.webp","width":1080,"height":608,"caption":"Easton Pharma's Oxazepam Receives NMPA Approval and Partners with Nhwa"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=34760#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Easton Pharma’s Oxazepam Receives NMPA Approval and Partners with Nhwa"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/0501.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34760"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34760\/revisions"}],"predecessor-version":[{"id":34762,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34760\/revisions\/34762"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/34761"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}